Kennedy ousts entire CDC vaccine advisory panel
Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
What happened
Health and Human Services Secretary Robert F. Kennedy Jr. Monday dismissed all 17 members of the Centers for Disease Control and Prevention's independent vaccine advisory committee, saying a "clean sweep is necessary to reestablish public confidence in vaccine science."
Kennedy, a longtime anti-vaccine activist who had criticized the panel of experts, said he would pick the committee's new members.
Who said what
The CDC's Advisory Committee on Immunization Practices wields "enormous influence," carefully reviewing and debating vaccine data and voting on "who should get the shots and when," The New York Times said. Once the CDC director signs off on the recommendations, insurance companies and government health agencies are required to cover the vaccines, so an "advisory panel more closely aligned" with Kennedy's views could "significantly alter — or even drop — the recommendations" for childhood vaccines and other immunizations.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Kennedy has the authority to dismiss ACIP members, but doing so in this manner "suggests a political, non-substantive motive," UC Law San Francisco vaccine policy expert Dorit Reiss told The Washington Post. "This will not restore trust in vaccines, and is not designed to do so."
What next?
Kennedy's purge appears to contradict a promise he made to Sen. Bill Cassidy (R-La.) to "maintain" the ACIP "without changes," in order to secure his key confirmation vote. Cassidy said on X Monday that the "fear is that the ACIP will be filled up with people who know nothing about vaccines except suspicion," but he would "continue to talk" to Kennedy "to ensure this is not the case." Kennedy did not break his promise, Cassidy told reporters, because his commitment was to maintain "the process, not the committee itself."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
The dazzling coral gardens of Raja AmpatThe Week Recommends Region of Indonesia is home to perhaps the planet’s most photogenic archipelago.
-
‘Never more precarious’: the UN turns 80The Explainer It’s an unhappy birthday for the United Nations, which enters its ninth decade in crisis
-
Trump’s White House ballroom: a threat to the republic?Talking Point Trump be far from the first US president to leave his mark on the Executive Mansion, but to critics his remodel is yet more overreach
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
How medical imposters are ruining health studiesUnder the Radar Automated bots and ‘lying’ individuals ‘threaten’ patient safety and integrity of research
-
Doctors sound the alarm about insurance company ‘downcoding’The Explainer ‘It’s blatantly disrespectful,’ one doctor said
-
Climate change is getting under our skinUnder the radar Skin conditions are worsening because of warming temperatures
-
Is this the end of ultraprocessed foods?Today's Big Question California law and the MAHA movement are on the same track
-
Bluetoothing: the phenomenon driving HIV spike in FijiUnder the Radar ‘Blood-swapping’ between drug users fuelling growing health crisis on Pacific island
-
Can TrumpRx really lower drug prices?Today’s Big Question Pfizer’s deal with Trump sent drugmaker stocks higher
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
